Table 2:

MR imaging data

Patient No.	Scan Date^*	Callosal Lesion	Shape	T2WI	T1WI	GD	DWI	ADC	Other Lesions	T2WI	T1WI	GD	DWI	ADC
1	Day 7 (3)	SCC	Extended	H	I	—	H	L	sym P WM	H	I	—	H	L
	Day 14	None							None
2	Day 2 (2)	None							sym F, P WM	I	I	NE	H	L
	Day 5	SCC	Extended	s1 H	I	NE	H	L	sym F, P WM	s1 H	I	NE	H	L
	Day 12	None							None
3	Day 4 (2)	SCC	Extended	sl H	I	NE	H	L	sym F, P WM	s1 H	I	NE	H	L
	Day 10	None							None
4	Day 1 (1)	None							None
	Day 2	SCC	Ovale	s1 H	I	—	H	L	None
	Day 7	None							F GM, WM	I	I	NE	H	L
	Day 70	None							F GM^†	s1 H	I	NE	I	I

Note:— GD indicates gadolinium enhancement; DWI, diffusion-weighted imaging; ADC, apparent difusion coefficient; SCC, splenum of corpus callosum; H, high signal; I, iso signal; L, low signal; NE, not examined; sym, symmetric; P, parietal; F, frontal; WM, white matter; GM, gray matter.
* Days after central nervous system manifestation are in parentheses following the scan date.
† Frontal atrophy.